Shares of Align Technology, Inc. (NASDAQ:ALGN – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the fourteen research firms that are covering the company, MarketBeat reports. Six investment analysts have rated the stock with a hold rating and eight have issued a buy rating on the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $205.8462.
Several research firms have recently weighed in on ALGN. Barclays raised shares of Align Technology from an “equal weight” rating to an “overweight” rating and set a $200.00 price target for the company in a research note on Tuesday, March 17th. UBS Group lifted their price target on shares of Align Technology from $175.00 to $185.00 and gave the company a “neutral” rating in a research note on Thursday, February 5th. Wells Fargo & Company lifted their price target on shares of Align Technology from $181.00 to $200.00 and gave the company an “overweight” rating in a research note on Thursday, February 5th. Robert W. Baird set a $218.00 price target on shares of Align Technology in a research note on Thursday, February 5th. Finally, Mizuho lifted their price target on shares of Align Technology from $200.00 to $215.00 and gave the company an “outperform” rating in a research note on Thursday, February 5th.
View Our Latest Analysis on ALGN
Institutional Investors Weigh In On Align Technology
Align Technology Price Performance
Shares of ALGN stock opened at $166.69 on Wednesday. The company has a market capitalization of $11.94 billion, a P/E ratio of 27.97, a P/E/G ratio of 1.74 and a beta of 1.67. The company’s 50-day simple moving average is $173.61 and its two-hundred day simple moving average is $168.68. Align Technology has a one year low of $122.00 and a one year high of $208.30.
Align Technology (NASDAQ:ALGN – Get Free Report) last posted its quarterly earnings results on Wednesday, April 29th. The medical equipment provider reported $2.58 earnings per share for the quarter, beating the consensus estimate of $2.26 by $0.32. Align Technology had a net margin of 10.50% and a return on equity of 15.82%. The firm had revenue of $1.04 billion during the quarter, compared to the consensus estimate of $1.02 billion. During the same quarter in the previous year, the firm posted $2.13 earnings per share. The company’s revenue was up 6.2% on a year-over-year basis. On average, research analysts expect that Align Technology will post 9.48 EPS for the current fiscal year.
Align Technology announced that its board has approved a stock repurchase plan on Wednesday, April 29th that allows the company to repurchase $200.00 million in shares. This repurchase authorization allows the medical equipment provider to buy up to 1.6% of its stock through open market purchases. Stock repurchase plans are generally an indication that the company’s board believes its stock is undervalued.
About Align Technology
Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.
The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.
Featured Articles
- Five stocks we like better than Align Technology
- Marvell Stock Soars on NVIDIA’s Trillion-Dollar Nod
- FirstCash Turns Pawn Into a Growth Machine
- HubSpot Just Crushed the Bear Case—Is a Bigger Rally Ahead?
- Aggressive Insider Buying Signals Opportunity in 3 Risky Stocks
Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.
